Pliant Therapeutics Inc. (PLRX)

AI Score

Unlock

1.32

-0.09 (-6.38%)

At close: Apr 03, 2025, 3:59 PM

1.26

-4.91%

After-hours: Apr 03, 2025, 07:59 PM EDT

Dividends

No dividend history available for Pliant Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

PLRX News

1 day ago · Pliant Therapeutics: An Activist On Deck - seekingalpha.com
1 week ago · PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know - zacks.com
2 weeks ago · INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - accessnewswire.com
1 month ago · Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder - benzinga.com
1 month ago · The Schall Law Firm Invites Shareholders With Losses In Pliant Therapeutics, Inc. To Join A Securities Fraud Investigation - accessnewswire.com
1 month ago · An Investigation Has Been Launched Into Pliant Therapeutics, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm - accessnewswire.com
1 month ago · INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX - accessnewswire.com
1 month ago · Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Shareholders to Inquire about Securities Investigation - accessnewswire.com
1 month ago · PLRX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Pliant Therapeutics, Inc. investment - accessnewswire.com
1 month ago · Investors Who Lost Money on Pliant Therapeutics, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - PLRX - accessnewswire.com